Previous studies, in which the same monoclonal antibody for Gd-IgA1 detection was used as in the present study, have consistently shown that patients with IgAN have elevated levels of serum Gd-IgA1 compared to patients with non-IgAN CKD and healthy controls [5, 7, 9]. The gene discussed is IGHA1; the disease is chronic kidney disease.